Poly Medicure Ltd Technical Momentum Shifts Amid Mixed Market Signals
NiveshIQ
NSE: POLYMED · Healthcare
Poly Medicure Ltd.
₹1,678.50▲ ₹30.80 (+1.87%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on POLYMED. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Poly Medicure Ltd.
Poly Medicure Limited is a leading Indian manufacturer and seller of medical devices, with a diverse product portfolio spanning infusion therapy, critical care, dialysis and renal care, cardiology, and vascular access products. The company generates revenue primarily from the sale of these medical devices in India and internationally. Key revenue drivers include the company's infusion therapy products, critical care products, and dialysis and renal care products. Recent developments indicate the company's growth prospects, with targets of 20% domestic growth and 16% international revenue hike in FY26. The Indian government's proposal to grant 50% faster approvals for Class B, C, and D devices is also expected to positively impact the company's business. With a strong product portfolio and
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,376 Cr +132.40% | ₹1,670 Cr +21.40% | ₹1,875 Cr +12.30% |
| EBITDA Margin | 25.94% | 32.46% | 29.99% |
| Net Profit | ₹258.00 Cr +136.70% | ₹338.56 Cr +31.20% | ₹321.85 Cr -4.90% |
| EPS | ₹26.92 | – | ₹31.79 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Poly Medicure Ltd Technical Momentum Shifts Amid Mixed Market Signals
Poly Medicure Ltd Technical Momentum Shifts Amid Mixed Market Signals
🔒
+ 3 more stories about Poly Medicure Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹441 Cr, PAT ₹92 Cr, EPS ₹6.54, EBITDA margin 32.6%. Growth context: revenue QoQ -10.8%, PAT QoQ +29.3%. Street verdict: miss, revenue surprise +0.1%, PAT surprise -9.2%.
Recent corporate activity highlights product launches, approvals, and therapy-mix improvement and geographic expansion a...
FY26 (last completed FY): revenue ₹1, 875 Cr, PAT ₹322 Cr, EBITDA margin 30.0%, EPS ₹31.79. Year-on-year: revenue YoY +1...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for POLYMED
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track POLYMED alongside your other holdings
Unlock full POLYMED research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Poly Medicure Ltd.?
NiveshIQ detects active intelligence signals for Poly Medicure Ltd. (POLYMED) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Poly Medicure Ltd.?
Poly Medicure Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,621,845.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.